Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Jacobson

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|December 2, 2005
Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-gamma-secreting T cellsJ E Ryan, I G Ovsyannikova, N Dhiman, et al.
Mayo Clinic Proceedings|September 1, 1995
Incidence of sudden infant death syndrome in Olmsted County, Minnesota: 1945 through 1992S A McLaughlin, M G Valdes, R M Jacobson, et al.
Vaccine|October 24, 2001
Identification of an association between HLA class II alleles and low antibody levels after measles immunizationG A Poland, I G Ovsyannikova, R M Jacobson, et al.
Human Immunology|February 22, 2001
High frequency of HLA-A*0103 allele in a Somali populationG A Poland, Y Sohni, M Domanico, et al.
JAMA|April 9, 1997
Measles reimmunization in children seronegative after initial immunizationG A Poland, R M Jacobson, A M Thampy, et al.
Vaccine|February 13, 2001
Correlations between measles, mumps, and rubella serum antibody levels in Olmsted County school childrenJ L St Sauver, R M Jacobson, R A Vierkant, et al.
Vaccine|April 9, 1999
Measles antibody seroprevalence rates among immunized Inuit, Innu and Caucasian subjectsG A Poland, R M Jacobson, S A Colbourne, et al.
Clinical and Experimental Immunology|November 22, 2005
Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccinationN Dhiman, I G Ovsyannikova, J E Ryan, et al.
Tissue Antigens|January 11, 2007
Childhood asthma and human leukocyte antigen typeY J Juhn, H Kita, L A Lee, et al.
Vaccine|August 7, 1999
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvantT C Heineman, M L Clements-Mann, G A Poland, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Clinical and Laboratory Investigation|December 2, 2005
Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-gamma-secreting T cellsJ E Ryan, I G Ovsyannikova, N Dhiman, et al.
Mayo Clinic Proceedings|September 1, 1995
Incidence of sudden infant death syndrome in Olmsted County, Minnesota: 1945 through 1992S A McLaughlin, M G Valdes, R M Jacobson, et al.
Vaccine|October 24, 2001
Identification of an association between HLA class II alleles and low antibody levels after measles immunizationG A Poland, I G Ovsyannikova, R M Jacobson, et al.
Human Immunology|February 22, 2001
High frequency of HLA-A*0103 allele in a Somali populationG A Poland, Y Sohni, M Domanico, et al.
JAMA|April 9, 1997
Measles reimmunization in children seronegative after initial immunizationG A Poland, R M Jacobson, A M Thampy, et al.
Vaccine|February 13, 2001
Correlations between measles, mumps, and rubella serum antibody levels in Olmsted County school childrenJ L St Sauver, R M Jacobson, R A Vierkant, et al.
Vaccine|April 9, 1999
Measles antibody seroprevalence rates among immunized Inuit, Innu and Caucasian subjectsG A Poland, R M Jacobson, S A Colbourne, et al.
Clinical and Experimental Immunology|November 22, 2005
Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccinationN Dhiman, I G Ovsyannikova, J E Ryan, et al.
Tissue Antigens|January 11, 2007
Childhood asthma and human leukocyte antigen typeY J Juhn, H Kita, L A Lee, et al.
Vaccine|August 7, 1999
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvantT C Heineman, M L Clements-Mann, G A Poland, et al.
Pageof 6